Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide

A Patil, U.N. Chirmade, V Trivedi, Dimitrios Lamprou, Andrew Urquhart, D. Douroumis

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Mesoporous silica nanoparticles MCM – 41 were synthesized with two dimensional hexagonal p6mm symmetry, high specific surface area(~ 980m2/g) narrow pore size and an average particle size of 186 nm. The produced nanoparticles were used to encapsulate carbamazepine through a supercritical carbon dioxide process combined with various organic solvents. Supercritical processing was found to provide increased drug encapsulation. The loaded MCM - 41 nanoparticles were analyzed using X–ray diffraction and differential scanning calorimetry (DSC) to investigate the crystalline state of the encapsulated carbamazepine and it was found to be dependent on the nature of the organic solvent. Carbamazepine showed increased dissolution rates under sink conditions. Viability studies of Caco – 2 cells demonstrated negligible cytotoxicity for the MCM–41 nanoparticles.
Original languageEnglish
Article number10.4172/2157-7439.1000111
JournalJournal of Nanomedicine and Nanotechnology
Volume2
Issue number3
DOIs
Publication statusPublished - Jul 2011

Keywords

  • nanoparticles
  • mesoporous silica
  • supercritical fluids
  • drug solubility
  • loading
  • cytotoxicity

Fingerprint Dive into the research topics of 'Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide'. Together they form a unique fingerprint.

  • Cite this

    Patil, A., Chirmade, U. N., Trivedi, V., Lamprou, D., Urquhart, A., & Douroumis, D. (2011). Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide. Journal of Nanomedicine and Nanotechnology , 2(3), [10.4172/2157-7439.1000111]. https://doi.org/10.4172/2157-7439.1000111